44
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Determination of pharmacokinetics of itraconazole in healthy Indian subjects under fed condition and incurred sample analysis using a validated liquid chromatography tandem mass spectrometric method

, , , , , & show all
Pages 35-40 | Received 23 Nov 2011, Accepted 09 Feb 2012, Published online: 22 Mar 2012

References

  • Grant S, Clissold S. Itraconazole: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in superficial and systemic mycoses. Drugs 1989;37:310–344.
  • Serajuddin ATM. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J Pharm Sci 1999;88:1058–1066.
  • Prentice AG, Glasmacher A. Making sense of Itraconazole pharmacokinetics. J Antimicrob Chemother 2005;56:17–87.
  • Amidon GL, Lennernas H, Shah VP, Crison JR. A theoretical basis for a bio pharmaceutics drug classification: the correlation of in vitro drug treatment dissolution and in vivo bioavailability. Pharm Res 1995;12:413–420.
  • International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH harmonized tripartite guideline. Guideline for Good Clinical Practice E6 (R1). Available online at: http://www.ich.org/ accessed 1 March 2010.
  • World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Amended by the 52nd WMA General Assembly, Edinburgh, Scotland, October 2000. Available online at: http://www.wma.net/en/30%20 publication/10%20 policies/index html accessed 1 March 2010.
  • Shargel L, Wu-Pong S, Yu A. Applied biopharmaceutics and pharmacokinetics: bioavailability & bioequivalence. 5th ed. New York: McGraw Hill; 2005. p 161.
  • Food and Drug Administration. Guidance for industry: statistical approaches to establishing bio equivalence. January 2001. Available online at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070244.pdf, accessed 07 May 2010.
  • Viswanathan CT, Bansal S, Booth B, DeStefano AJ, Rose MJ, Sailstad J, Shah VP, Skelly JP, Swann PG, Weiner R. Workshop/conference report–quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays. AAPS Journal 2007;9:E30–E42.
  • Patni AK, Monif T, Khuro AH, Iyer Sunil S, Tiwary AK. Validated liquid chromatography tandem mass spectrometric method for quantification of Itraconazole and Hydroxy Itraconazolein human plasma for pharmacokinetic study. Der Pharmacia Lettre 2010;2:41–53.
  • Li-Jun Y, Yun-Gui Z. Pharmacokinetics and bioequivalence of Itraconazole capsules in healthy volunteers after high fat diet. Chin J Pharmaceut 2009-07.
  • Public Assessment Report, Itraconazole 100mg Capsules UK/H/1317/01/DC UK license no: PL 20796/0007. 2009.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.